FDA Approves GlaxoSmithKline's Abreva

Treating cold sores or fever blisters on the face or lips and shortening the duration of symptoms (eg, tingling, pain, itching, burning).

ABREVA works like a prescription without one! ABREVA is the only non-prescription medication approved by the FDA that is proven to shorten healing time.

While other products merely soothe a cold sore, ABREVA speeds healing by going deep beneath the skin to heal from the inside out. So you can take control of cold sores the moment they strike.

Docosanol, also known as behenyl alcohol, is a saturated fatty alcohol used traditionally as an emollient, emulsifier, and thickener in cosmetics, nutritional supplement (as an individual entity and also as a constituent of polyicosanol), and more recently, in a Food and Drug Administration (FDA) approved pharmaceutical, Abreva, approved for reducing the duration of "cold sores" caused by the herpes simplex virus.

Abreva is a docosanol 10% cream for the topical treatment of recurrent oral-facial herpes simplex episodes (cold sores or fever blisters). The active ingredient is n-docosanol, also known as behenyl alcohol, a saturated 22-carbon aliphatic alcohol which exhibits antiviral activity against many lipid enveloped viruses including herpes simplex virus (HSV).

It is being marketed by SmithKline Beecham and will be available without prescription in the over-the-counter market.